首页 | 本学科首页   官方微博 | 高级检索  
     

脂肝康药效学研究
引用本文:岳南,只德广,赵益桂,苏雅,陈芙蓉. 脂肝康药效学研究[J]. 药物评价研究, 2010, 0(6): 416-419
作者姓名:岳南  只德广  赵益桂  苏雅  陈芙蓉
作者单位:天津药物研究院新药评价中心,天津300193
摘    要:目的:观察脂肝康对动物实验性脂肪肝的治疗作用。方法:采用乙硫氨酸、高脂饲料复制动物脂肪肝模型,iv高分子右旋糖苷复制大鼠"血瘀"模型,观察脂肝康的作用。结果:脂肝康能明显降低实验性脂肪肝动物肝脏、血液中的总胆固醇(TC)、三酰甘油(TG)的量;明显抑制"血瘀"大鼠全血粘度的升高。结论:脂肝康对脂肪肝大鼠有明显的治疗作用。

关 键 词:血瘀  脂肪肝  TC  TG  脂肝康

Pharmacodynamic study of Zhigankang
YUE Nan,ZHI De-guang,ZHAO Yi-gui,SU Ya,CHEN Fu-rong. Pharmacodynamic study of Zhigankang[J]. Drug Evaluation Research, 2010, 0(6): 416-419
Authors:YUE Nan  ZHI De-guang  ZHAO Yi-gui  SU Ya  CHEN Fu-rong
Affiliation:(Center for Drug Evaluation and Research, Tianjin Institute of Pharmaceutical Reseach, Tianjin 300193, China)
Abstract:Objective:To investigate the therapeutic effect of Zhigankang on experimental fatty liver.Methods:To observe the effect of Zhigankang on "blood stasis" of rats that were fed with ethionine,high-fat food,or by iv injection of high molecular Dextran.Results:Zhigankang significantly reduced TC and TG content in liver and blood of rats and inhibited the increase of whole blood viscosity in "blood stasis" rats.Conclusion:Zhigankang has obvious therapeutic effect on fatty liver in rats
Keywords:blood stasis  fatty liver  TC  TG  Zhigankang
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号